Indication
Chronic Progressive
3 clinical trials
4 products
1 drug
Product
NurOwnClinical trial
A Phase 2 Open-label Multicenter Study to Evaluate the Safety and Efficacy of Repeated Administration of NurOwn® [Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors (NTF), MSC-NTF] Cells in Participants With Progressive MSStatus: Completed, Estimated PCD: 2021-03-11
Clinical trial
A Randomized, Double-Blind, Delayed Treatment, Placebo-Controlled Trial to Assess the Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair TherapyStatus: Recruiting, Estimated PCD: 2025-06-01
Product
ClemastineDrug
VarlilumabClinical trial
Tolerance-Induction With Dendritic Cells Treated With Vitamin-D3 and Loaded With Myelin Peptides, in Multiple Sclerosis Patients (TOLERVIT-MS)Status: Recruiting, Estimated PCD: 2023-12-01
Product
Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptidesProduct
Interferon-beta